These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10431162)

  • 21. Introduction to special issue on Alzheimer's disease.
    Wolfe MS
    J Med Chem; 2012 Nov; 55(21):8977-8. PubMed ID: 23039833
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of amyloid β1-42 and neuroimaging biomarkers in Alzheimer's disease.
    Lista S; Emanuele E
    Biomark Med; 2011 Aug; 5(4):411-3. PubMed ID: 21861661
    [No Abstract]   [Full Text] [Related]  

  • 23. Overexpression of Amyloid Precursor Protein Promotes the Onset of Seborrhoeic Keratosis and is Related to Skin Ageing.
    Li Y; Wang Y; Zhang W; Jiang L; Zhou W; Liu Z; Li S; Lu H
    Acta Derm Venereol; 2018 Jun; 98(6):594-600. PubMed ID: 29487944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymes point way to potential Alzheimer's therapies.
    Pennisi E
    Science; 1999 Oct; 286(5440):650-1. PubMed ID: 10577210
    [No Abstract]   [Full Text] [Related]  

  • 25. Beta-amyloid peptide in regulated secretory vesicles of chromaffin cells: evidence for multiple cysteine proteolytic activities in distinct pathways for beta-secretase activity in chromaffin vesicles.
    Hook VY; Toneff T; Aaron W; Yasothornsrikul S; Bundey R; Reisine T
    J Neurochem; 2002 Apr; 81(2):237-56. PubMed ID: 12064471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of beta-secretase.
    Stephens DJ; Austen BM
    Biochem Soc Trans; 1998 Aug; 26(3):500-4. PubMed ID: 9765904
    [No Abstract]   [Full Text] [Related]  

  • 27. Identifying proteases that cleave APP.
    Citron M
    Ann N Y Acad Sci; 2000; 920():192-6. PubMed ID: 11193149
    [No Abstract]   [Full Text] [Related]  

  • 28. [gamma secretase].
    Ihara Y
    Seikagaku; 2002 Jun; 74(6):449-54. PubMed ID: 12138705
    [No Abstract]   [Full Text] [Related]  

  • 29. [Unique structures of Alzheimer's gamma-secretase].
    Shirotani K
    Seikagaku; 2006 Jun; 78(6):537-40. PubMed ID: 16856568
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
    Tang K; Hynan LS; Baskin F; Rosenberg RN
    J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
    Evin G; Cappai R; Li QX; Culvenor JG; Small DH; Beyreuther K; Masters CL
    Biochemistry; 1995 Oct; 34(43):14185-92. PubMed ID: 7578016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrillogenesis of beta-amyloid.
    Allsop D; Howlett D; Christie G; Karran E
    Biochem Soc Trans; 1998 Aug; 26(3):459-63. PubMed ID: 9765896
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease.
    Colciaghi F; Marcello E; Borroni B; Zimmermann M; Caltagirone C; Cattabeni F; Padovani A; Di Luca M
    Neurology; 2004 Feb; 62(3):498-501. PubMed ID: 14872043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
    Selkoe DJ
    J Clin Invest; 2002 Nov; 110(10):1375-81. PubMed ID: 12438432
    [No Abstract]   [Full Text] [Related]  

  • 35. Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
    Lee HG; Perry G; Zhu X; Nunomura A; Smith MA
    Free Radic Biol Med; 2006 Jul; 41(2):188-9. PubMed ID: 16814097
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recent advances in Alzheimer's disease-related gamma-secretase complex].
    Tomita T; Iwatsubo T
    Seikagaku; 2004 Jul; 76(7):666-70. PubMed ID: 15346905
    [No Abstract]   [Full Text] [Related]  

  • 37. Alzheimer's disease: finding the missing link.
    Senior K
    Mol Med Today; 1999 May; 5(5):188-9. PubMed ID: 10322307
    [No Abstract]   [Full Text] [Related]  

  • 38. The functional gamma-secretase inhibitor prevents production of amyloid beta 1-34 in human and murine cell lines.
    Vandermeeren M; Geraerts M; Pype S; Dillen L; Van Hove C; Mercken M
    Neurosci Lett; 2001 Nov; 315(3):145-8. PubMed ID: 11716984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.
    Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP
    J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization.
    Schenk D; Games D; Seubert P
    J Mol Neurosci; 2001 Oct; 17(2):259-67. PubMed ID: 11816797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.